Christopher Simon - Jun 6, 2024 Form 4 Insider Report for HAEMONETICS CORP (HAE)

Role
President & CEO, Director
Signature
/s/ Thomas V. Powers, attorney-in-fact for Mr. Simon
Stock symbol
HAE
Transactions as of
Jun 6, 2024
Transactions value $
-$1,881,206
Form type
4
Date filed
6/7/2024, 04:15 PM
Previous filing
May 29, 2024
Next filing
Aug 9, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HAE Common Stock Options Exercise $4.35M +105K +31.73% $41.64 434K Jun 6, 2024 Direct F1, F2
transaction HAE Common Stock Tax liability -$6.23M -71.3K -16.44% $87.38 363K Jun 6, 2024 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HAE Non-qualified Stock Option (Right to Buy) Options Exercise $0 -105K -100% $0.00* 0 Jun 6, 2024 Common Stock 105K $41.64 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an automatic exercise of options granted in 2017 and scheduled to expire after June 6, 2024, as reflected in this Form 4.
F2 This number includes unvested restricted stock units previously reported.
F3 Represents shares withheld for tax obligations and for payment of the exercise price on exercised stock options reported in Table I.
F4 Option vests in annual increments of 25% beginning on the first anniversary of the date of grant.